{
    "clinical_study": {
        "@rank": "161648", 
        "brief_summary": {
            "textblock": "To study the natural course of AIDS related Kaposi's sarcoma and to determine the usefulness\n      and safety of weekly administration of small doses of doxorubicin.\n\n      Doxorubicin is one of the most active of all antitumor agents but at currently used doses\n      toxicity is common. When small doses are administered on a weekly schedule, the toxicity of\n      the drug appears to be reduced."
        }, 
        "brief_title": "A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma", 
        "completion_date": {
            "#text": "June 1990", 
            "@type": "Actual"
        }, 
        "condition": [
            "Sarcoma, Kaposi", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Sarcoma, Kaposi", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Doxorubicin is one of the most active of all antitumor agents but at currently used doses\n      toxicity is common. When small doses are administered on a weekly schedule, the toxicity of\n      the drug appears to be reduced.\n\n      Patients are stratified for non-therapy purposes into 2 groups; doxorubicin is given\n      intravenously (IV) every week on an outpatient basis. Patients are monitored carefully, and\n      weekly blood samples are taken to determine the effectiveness and safety of treatment.\n      Patients are evaluated for toxicity after one dose of the drug and weekly thereafter.\n      Patients are evaluated for response to the drug after 4 weeks and monthly thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Ongoing and/or maintenance therapy for opportunistic infection.\n\n          -  Medications for nausea, vomiting, and diarrhea resulting from drug.\n\n        Patients must have AIDS related Kaposi's sarcoma.\n\n          -  Patients may demonstrate positive blood cultures for Mycobacterium avium-complex or\n             cytomegalovirus.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions will be excluded:\n\n          -  Patients with active opportunistic infection.\n\n          -  Patients with concurrent neoplasm other than squamous cell carcinoma of the skin or\n             in situ carcinoma of the cervix.\n\n          -  Patients with significant neurologic, cardiac, or liver disease.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Antiretroviral agents.\n\n          -  Immunomodulators.\n\n          -  Corticosteroids.\n\n          -  Experimental drugs.\n\n        The following patients will be excluded from the study:\n\n          -  Patients with lymphadenopathy alone and/or visceral disease alone secondary to\n             Kaposi's sarcoma.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Cytotoxic chemotherapy.\n\n          -  Excluded within 30 days of study entry:\n\n          -  Antiretroviral agents.\n\n          -  Biologic modifiers.\n\n          -  Corticosteroids.\n\n        Prior Treatment:\n\n        Excluded:\n\n          -  Total body electron beam therapy.\n\n          -  Excluded within 30 days of study entry:\n\n          -  Radiation therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "48", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000996", 
            "org_study_id": "ACTG 006", 
            "secondary_id": "10982"
        }, 
        "intervention": {
            "intervention_name": "Doxorubicin hydrochloride", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Doxorubicin"
        }, 
        "keyword": [
            "Doxorubicin", 
            "Drug Evaluation", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "March 15, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA CARE Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "941102859"
                    }, 
                    "name": "San Francisco AIDS Clinic / San Francisco Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "331361013"
                    }, 
                    "name": "Univ of Miami School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Charity Hosp / Tulane Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane Univ School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Deaconess - West Campus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }, 
                    "name": "SUNY / Erie County Med Ctr at Buffalo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Mem Sloan - Kettering Cancer Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Bellevue Hosp / New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ of Rochester Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "432101228"
                    }, 
                    "name": "Ohio State Univ Hosp Clinic"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Phase II Study of Weekly Doxorubicin Treatment of AIDS Associated Kaposi's Sarcoma", 
        "overall_official": {
            "last_name": "MA Fischl", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "reference": [
            {
                "citation": "Walker RE, et al. The safety, pharmacokinetics, and antiviral activity of N-acetylcysteine in HIV-infected individuals. Int Conf AIDS. 1992 Jul 19-24;8(1):Mo8 (abstract no MoB 0022)"
            }, 
            {
                "PMID": "8450401", 
                "citation": "Fischl MA, Krown SE, O'Boyle KP, Mitsuyasu R, Miles S, Wernz JC, Volberding PA, Kahn J, Groopman JE, Feinberg J, et al. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J Acquir Immune Defic Syndr. 1993 Mar;6(3):259-64."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000996"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Bellevue Hosp / New York Univ Med Ctr": "40.714 -74.006", 
        "Beth Israel Deaconess - West Campus": "42.358 -71.06", 
        "Charity Hosp / Tulane Univ Med School": "29.951 -90.072", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Mem Sloan - Kettering Cancer Ctr": "40.714 -74.006", 
        "Ohio State Univ Hosp Clinic": "39.961 -82.999", 
        "SUNY / Erie County Med Ctr at Buffalo": "42.886 -78.878", 
        "San Francisco AIDS Clinic / San Francisco Gen Hosp": "37.775 -122.419", 
        "Tulane Univ School of Medicine": "29.951 -90.072", 
        "UCLA CARE Ctr": "34.052 -118.244", 
        "Univ of Miami School of Medicine": "25.789 -80.226", 
        "Univ of Rochester Medical Center": "43.161 -77.611"
    }
}